Results 181 to 190 of about 302,337 (268)

Meeting Report: Research Topics in Gastrointestinal Disease VIII

Canadian Journal of Gastroenterology, 2009
Gordon R Greenberg, Ken Croitoru, Stephen Vanner, George Tolomiczenko, Louise Hope   +4 more
doaj   +1 more source

Neutrophil Irg1/itaconate axis protects against experimental colitis by suppressing local inflammation and maintaining hematopoietic homeostasis. [PDF]

Mol Biomed
Zhao N, Wang G, Long S, Chen Y, Gao J, Lv X, Ran X, Jia Y, Wang T.   +8 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic‐Experienced Patients With Ulcerative Colitis: A Retrospective Study [PDF]

Neta Sror, Haim Leibovitzh, Ayal Hirsch, Tamar Thurm, Yulia Ron, Nitsan Maharshak, Nathaniel A. Cohen   +6 more
openalex   +1 more source

The causal relationship between systemic lupus erythematosus and juvenile myoclonic epilepsy: A Mendelian randomization study and mediation analysis

Ibrain, Volume 11, Issue 1, Page 98-105, Spring 2025.
Mendelian randomization (MR) studies were conducted using the inverse‐variance weighted (IVW) method, MR‐Egger and weighted median on juvenile myoclonic epilepsy (JME), and systemic lupus erythematosus (SLE) data from the Integrative Epidemiology Unit (IEU) Open genome‐wide association study (GWAS) database and the International League Against Epilepsy
Sirui Chen, Ningning Zhang, Ruirui Zhang, Lan Zhang, Dadong Luo, Junqiang Li, Yaqing Liu, Yunan Wang, Xinyue Duan, Xin Tian, Tiancheng Wang   +10 more
wiley   +1 more source

Probing the activity of cysteine cathepsins in inflammatory bowel diseases. [PDF]

Sci Rep
Anderson BM, Ziegler AR, Campden RI, Wu H, Xu B, McQuade RM, Carbone SE, Poole DP, Lomax AE, Reed DE, Vanner SJ, Yates RM, Bunnett NW, Edgington-Mitchell LE.   +13 more
europepmc   +1 more source

Ulcerative colitis and pericarditis.

, 1979
Casper Emil Christensen
openalex   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

International Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Carmen González Arenas, Zhenghong Chen, Wen Cheng Yu, Tony S. K. Mok   +14 more
wiley   +1 more source

Heterogeneity in Histological Evaluation of Microscopic Colitis in Randomized Clinical Trials: An Umbrella Review. [PDF]

Inflamm Bowel Dis
Yuan Y, Kerchove KV, Ma C, Verstockt B, Nardone OM, Bernstein CN, Munch A, Jairath V.   +7 more
europepmc   +1 more source

Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis [PDF]

Virginia Solitano, Malcolm Hogan, Siddharth Singh, Silvio Danese, Laurent Peyrin-Biroulet, Sudheer K. Vuyyuru, John K MacDonald, Guangyong Zou, Yuhong Yuan, Bruce E. Sands, Remo Panaccione, Brian G. Feagan, Jurij Hanžel, Rocío Sedaño, Parambir Dulai, Neeraj Narula, Christopher Ma, Vipul Jairath   +17 more
openalex   +1 more source

Clinical Characteristics and Risk Factors for Pneumocystis Jirovecii Pneumonia during Immunosuppressive Treatment in Patients with Ulcerative Colitis: A Retrospective Study

, 2020
Kentaro Kojima, Toshiyuki Sato, Motoi Uchino, Yoko Yokoyama, Tetsuya Takagawa, Yoshio Ohda, Nobuyuki Hida, Kenji Watanabe, Kazutoshi Hori, Hiroto Miwa, Hiroki Ikeuchi, Shirô Nakamura, Masahito Shimizu   +12 more
openalex   +2 more sources